Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Trial of Alpha-1 Antitrypsin Augmentation Therapy in Patients With Bronchiectasis

NCT05582798 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.

NCT NCT05582798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05582798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Trial of Alpha-1 Antitrypsin Augmentation Therapy in Patients With Bronchiectasis
Lead sponsor
University of Dundee
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2022
Completion date
August 12, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis adult